
Strep A Pathogen Testing with Acutis Reveal™
Acutis Reveal™ PIT is an FDA-cleared molecular test that quickly identifies the Group A β-hemolytic Streptococcus pyogenes pathogen responsible for Strep A disease.
Acutis Reveal™ Acutis Reveal™ PIT (Strep A) is an FDA-cleared molecular test that quickly identifies the Group A β-hemolytic Streptococcus pyogenes pathogen responsible for Strep A disease.
Acutis Reveal™ PIT (Strep A) is an FDA-cleared molecular test that quickly identifies the Group A β-hemolytic Streptococcus pyogenes pathogen responsible for Strep A disease.
Start testing with us today
Benefits of Acutis Reveal™ PIT at a glance
1
fast one-step treatment that requires only a simple throat swab and transport media
2
Rapid confirmation, within 24 hours from the time a sample is received
3
New degrees of certainty determine whether the illness is bacterial or viral in nature, and so whether a course of antibiotics is necessary
4
Highly accurate data confirms best treatment options and outcomes for your patients
5
Streamlined patient management, which eliminates costs, while relieving patients, particularly parents of children
The FDA-cleared molecular detection test that simplifies the clinical scenario

The FDA-approved test detects the major pharyngeal pathogen responsible for Strep A:
bacterial targets
-
Streptococcus pyogenes
If you have any questions about theAcutis Reveal™ Strep A test
Our molecular disease relations experts are available to speak with you to provide the information you need, to make individual test selections, based on your diagnoses and medical necessity.Discover all our Acutis Reveal™ tests for infectious diseases




